|
|
||||||||
Ann Thorac Surg 1998;65:1310-1312
© 1998 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, University of Regensburg, Regensburg, Germany
Accepted for publication December 16, 1997.
Address reprint requests to Dr Wahba, Klinik für Herz-, Thorax- und herznahe Gefäßchirurgie, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany
e-mail: (wahba{at}klinik.uni.regensburg.de)
Background. The development of an abnormal pressure gradient (APG) across the oxygenator is the most common cause of oxygenator failure during cardiopulmonary bypass. This necessitated changing the oxygenator in 4 patients in this series. A retrospective analysis of conditions predisposing to APG was performed.
Methods. One thousand nine hundred fifty-nine operations with cardiopulmonary bypass were performed in adults. A range of membrane oxygenators was used subject to availability; 769 oxygenators were heparin-coated and 1,190 were uncoated. The pressure gradient across the oxygenator was measured under standardized conditions. An APG was defined as a gradient of greater than twice the mean.
Results. An APG occurred in 44 uncoated and 3 heparin-coated oxygenators (p < 0.001). The mean age was higher for the APG group (p < 0.001). Fibrin deposits in the arterial line filter were noted in 45 patients. Logistic regression revealed that only fibrin deposition in the arterial line filter and the use of uncoated oxygenators were significantly associated with APG.
Conclusions. We conclude that a heparin-coated oxygenator effectively prevents APG. This adds significantly to the safety of open heart operations.
This article has been cited by other articles:
![]() |
R. Lorusso, G. De Cicco, P. Totaro, and S. Gelsomino Effects of phosphorylcholine coating on extracorporeal circulation management and postoperative outcome: a double-blind randomized study Interactive CardioVascular and Thoracic Surgery, January 1, 2009; 8(1): 7 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Hammon Extracorporeal Circulation: Perfusion System Card. Surg. Adult, January 1, 2008; 3(2008): 350 - 370. [Full Text] |
||||
![]() |
U Da Broi, V Adami, E Falasca, W Malangone, S Crini, and A Degrassi A new oxygenator change-out system and procedure Perfusion, September 1, 2006; 21(5): 297 - 303. [Abstract] [PDF] |
||||
![]() |
L. K von Segesser, P. Tozzi, I. Mallbiabrrena, D. Jegger, J. Horisberger, and A. Corno Miniaturization in cardiopulmonary bypass Perfusion, July 1, 2003; 18(4): 219 - 224. [Abstract] [PDF] |
||||
![]() |
L. K. von Segesser Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S90 - 91. [Full Text] [PDF] |
||||
![]() |
A. R. Fisher, M. Baker, M. Buffin, P. Campbell, S. Hansbro, S. Kennington, A. Lilley, and M. Whitehorne Normal and abnormal trans-oxygenator pressure gradients during cardiopulmonary bypass Perfusion, January 1, 2003; 18(1): 25 - 30. [Abstract] [PDF] |
||||
![]() |
E. A. Hessel II and L. H. Edmunds Jr. Extracorporeal Circulation: Perfusion Systems Card. Surg. Adult, January 1, 2003; 2(2003): 317 - 338. [Full Text] |
||||
![]() |
L.-C. Hsu Heparin-coated cardiopulmonary bypass circuits: current status Perfusion, September 1, 2001; 16(5): 417 - 428. [Abstract] [PDF] |
||||
![]() |
H. P Wendel, A. Philipp, N. Weber, D. E Birnbaum, and G. Ziemer Oxygenator thrombosis: worst case after development of an abnormal pressure gradient - incidence and pathway Perfusion, July 1, 2001; 16(4): 271 - 278. [Abstract] [PDF] |
||||
![]() |
L. K. von Segesser Safety and efficacy of heparin-bonded surfaces in cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0200 - 201. [Full Text] [PDF] |
||||
![]() |
B. L Mejak, A. Stammers, E. Rauch, S. Vang, and T. Viessman A retrospective study on perfusion incidents and safety devices Perfusion, January 1, 2000; 15(1): 51 - 61. [Abstract] [PDF] |
||||
![]() |
J. Schaadt Oxygenator thrombosis: an international phenomenon Perfusion, December 1, 1999; 14(6): 425 - 435. [Abstract] [PDF] |
||||
![]() |
H. P. Wendel and G. Ziemer Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation Eur. J. Cardiothorac. Surg., September 1, 1999; 16(3): 342 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wimmer-Greinecker, G. Matheis, S. Martens, G. Oremek, U. Abdel-Rahman, and A. Moritz Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences Eur. J. Cardiothorac. Surg., August 1, 1999; 16(2): 211 - 217. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |